$HIMS
Hims & Hers Health, Inc.

2021 Q3 Form 10-Q Financial Statement

#000177375121000057 Filed on November 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3 2020 Q2
Revenue $74.17M $41.32M $35.90M
YoY Change 79.49%
Cost Of Revenue $19.30M $10.05M $10.24M
YoY Change 92.11%
Gross Profit $54.87M $31.28M $25.66M
YoY Change 75.44%
Gross Profit Margin 73.98% 75.69% 71.47%
Selling, General & Admin $44.24M $19.50M $14.84M
YoY Change 126.92% 4232.44%
% of Gross Profit 80.62% 62.33% 57.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.546M
YoY Change
% of Gross Profit 2.82%
Operating Expenses $82.53M $34.60M $26.64M
YoY Change 138.55% 7588.44%
Operating Profit -$27.66M -$3.321M -$979.0K
YoY Change 732.91% 638.1% 5795.46%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $8.547M -$2.519M $35.00K
YoY Change -439.3% -384.32%
Pretax Income -$19.11M -$5.840M -$944.0K
YoY Change 227.29% -1427.27%
Income Tax -$3.173M $31.00K $37.00K
% Of Pretax Income
Net Earnings -$15.94M -$5.871M -$981.0K
YoY Change 171.52% -1446.42% 5807.5%
Net Earnings / Revenue -21.49% -14.21% -2.73%
Basic Earnings Per Share -$0.08 -$0.16 -$0.03
Diluted Earnings Per Share -$0.08 -$0.16 -$0.03
COMMON SHARES
Basic Shares Outstanding 200.0M shares 35.61M shares 35.33M shares
Diluted Shares Outstanding 200.0M shares 35.61M shares 35.33M shares

Balance Sheet

Concept 2021 Q3 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $252.4M $1.300M $1.400M
YoY Change 19317.31% -27.78%
Cash & Equivalents $64.77M $1.258M $1.386M
Short-Term Investments $187.7M
Other Short-Term Assets $716.0K $100.0K $100.0K
YoY Change 616.0% -50.0%
Inventory $10.86M
Prepaid Expenses $8.910M $75.15K $90.20K
Receivables $1.324M
Other Receivables $0.00
Total Short-Term Assets $274.2M $1.333M $1.476M
YoY Change 20476.46% -31.96%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $110.9M
YoY Change
Intangibles $26.93M
YoY Change
Long-Term Investments $204.5M $204.7M
YoY Change 1.19%
Other Assets $7.167M
YoY Change
Total Long-Term Assets $145.8M $204.5M $204.7M
YoY Change -28.68% 1.16%
TOTAL ASSETS
Total Short-Term Assets $274.2M $1.333M $1.476M
Total Long-Term Assets $145.8M $204.5M $204.7M
Total Assets $420.1M $205.8M $206.2M
YoY Change 104.1% 0.84% 38347.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.09M $24.71K $21.66K
YoY Change 65023.62% -94.8% -1.47%
Accrued Expenses $11.21M $2.579M $535.9K
YoY Change 334.51% 443.3% 19.33%
Deferred Revenue $1.993M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $52.50M $3.038M $1.168M
YoY Change 1628.2% 192.97% 121.19%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.218M $7.200M $7.200M
YoY Change -83.08% 0.0%
Total Long-Term Liabilities $1.218M $7.200M $7.200M
YoY Change -83.08% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $52.50M $3.038M $1.168M
Total Long-Term Liabilities $1.218M $7.200M $7.200M
Total Liabilities $64.92M $10.23M $8.361M
YoY Change 534.47% 24.31% 1572.29%
SHAREHOLDERS EQUITY
Retained Earnings -$247.8M $137.7K $2.395M
YoY Change -180002.13% -67.16% -14519.54%
Common Stock $603.0M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $355.2M -$143.3M -$138.9M
YoY Change
Total Liabilities & Shareholders Equity $420.1M $205.8M $206.2M
YoY Change 104.1% 0.84% 38347.19%

Cashflow Statement

Concept 2021 Q3 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$15.94M -$5.871M -$981.0K
YoY Change 171.52% -1446.42% 5807.5%
Depreciation, Depletion And Amortization $1.546M
YoY Change
Cash From Operating Activities -$15.96M -$460.0K -$90.00K
YoY Change 3369.57% 119.05%
INVESTING ACTIVITIES
Capital Expenditures -$1.566M
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$24.36M $330.0K
YoY Change -7480.61% -100.16%
Cash From Investing Activities -$25.92M $330.0K
YoY Change -7955.15% -100.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -484.0K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -15.96M -460.0K -90.00K
Cash From Investing Activities -25.92M 330.0K
Cash From Financing Activities -484.0K 0.000
Net Change In Cash -42.37M -130.0K -90.00K
YoY Change 32489.23% -107.3%
FREE CASH FLOW
Cash From Operating Activities -$15.96M -$460.0K -$90.00K
Capital Expenditures -$1.566M
Free Cash Flow -$14.39M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001773751
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
HIMS & HERS HEALTH, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity File Number
EntityFileNumber
001-38986
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1482650
dei Entity Address Address Line1
EntityAddressAddressLine1
2269 Chestnut Street, #523
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94123
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
851-0195
dei Security12b Title
Security12bTitle
Class A common stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
HIMS
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64772000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27344000 USD
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
187653000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
72864000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
10858000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
3543000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10950000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5404000 USD
CY2021Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
0 USD
CY2020Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
3929000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
274233000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
113084000 USD
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
856000 USD
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1006000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7167000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4548000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26932000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
59000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
110881000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
0 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
16094000 USD
CY2021Q3 us-gaap Assets
Assets
420069000 USD
CY2020Q4 us-gaap Assets
Assets
118697000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8066000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11206000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4984000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1993000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1272000 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
23205000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 USD
CY2021Q3 hims Warrants And Rights Outstanding Current
WarrantsAndRightsOutstandingCurrent
0 USD
CY2020Q4 hims Warrants And Rights Outstanding Current
WarrantsAndRightsOutstandingCurrent
906000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
52498000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15228000 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
11200000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1218000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
381000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
64916000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
15609000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
275000000 shares
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
95997674 shares
CY2021Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2021Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
93328118 shares
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
93328118 shares
CY2021Q3 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
0 USD
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
268452000 USD
CY2021Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
249962000 USD
CY2021Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
249962000 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
20000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
602975000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
24429000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-52000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-247790000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-171292000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
355153000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-146874000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
420069000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
118697000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74173000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41324000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
187179000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
107291000 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
19301000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
10047000 USD
us-gaap Cost Of Revenue
CostOfRevenue
44783000 USD
us-gaap Cost Of Revenue
CostOfRevenue
29733000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
54872000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
31277000 USD
us-gaap Gross Profit
GrossProfit
142396000 USD
us-gaap Gross Profit
GrossProfit
77558000 USD
CY2021Q3 us-gaap Marketing Expense
MarketingExpense
38293000 USD
CY2020Q3 us-gaap Marketing Expense
MarketingExpense
15102000 USD
us-gaap Marketing Expense
MarketingExpense
93195000 USD
us-gaap Marketing Expense
MarketingExpense
39675000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44240000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19496000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
142678000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48401000 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
82533000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
34598000 USD
us-gaap Operating Expenses
OperatingExpenses
235873000 USD
us-gaap Operating Expenses
OperatingExpenses
88076000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-27661000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3321000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-93477000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-10518000 USD
CY2021Q3 hims Fair Value Adjustment Of Liabilities
FairValueAdjustmentOfLiabilities
-8328000 USD
CY2020Q3 hims Fair Value Adjustment Of Liabilities
FairValueAdjustmentOfLiabilities
2527000 USD
hims Fair Value Adjustment Of Liabilities
FairValueAdjustmentOfLiabilities
-13610000 USD
hims Fair Value Adjustment Of Liabilities
FairValueAdjustmentOfLiabilities
2477000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
0 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
10000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
219000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
320000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
223000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8547000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2519000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13930000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2264000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19114000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5840000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-79547000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12782000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3173000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3049000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
103000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-15941000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-5871000 USD
us-gaap Net Income Loss
NetIncomeLoss
-76498000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12885000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-41000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15953000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5865000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-76539000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12897000 USD
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
200038761 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
200038761 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35614598 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35614598 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
181867522 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181867522 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35345972 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35345972 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-146874000 USD
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
21902000 USD
CY2021Q1 hims Adjustments To Additional Paid In Capital Warrant Conversion
AdjustmentsToAdditionalPaidInCapitalWarrantConversion
1160000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
249837000 USD
CY2021Q1 hims Adjustments To Additional Paid In Capital Related Party Receivable Repayment
AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment
854000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
16200000 USD
CY2021Q1 hims Stock Issued During Period Value Reverse Recapitalization
StockIssuedDuringPeriodValueReverseRecapitalization
129659000 USD
CY2021Q1 hims Stock Issued During Period Value Contingent Consideration Reverse Recapitalization
StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization
1000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
80000 USD
CY2021Q1 hims Adjustments To Additional Paid In Capital Early Exercised Options Vested
AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested
54000 USD
CY2021Q1 hims Adjustments To Additional Paid In Capital Recapitalization Warrant Expense
AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense
154000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34230000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-61000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-51404000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
292466000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2500000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1949000 USD
CY2021Q2 hims Stock Issued During Period Value Restricted Stock Award Net Of Tax Withholdings
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfTaxWithholdings
-1958000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
178000 USD
CY2021Q2 hims Adjustments To Additional Paid In Capital Early Exercised Options Vested
AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested
48000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9491000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
32000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-9153000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
293054000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
50665000 USD
CY2021Q3 hims Stock Issued During Period Value Restricted Stock Award Net Of Tax Withholdings
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfTaxWithholdings
-651000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
313000 USD
CY2021Q3 hims Adjustments To Additional Paid In Capital Early Exercised Options Vested
AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested
41000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10717000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-15941000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
355153000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-139793000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
100000 USD
CY2020Q1 hims Adjustments To Additional Paid In Capital Early Exercised Options Vested
AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested
11000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1404000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
4500000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-42000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-6033000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-139953000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
27000 USD
CY2020Q2 hims Adjustments To Additional Paid In Capital Early Exercised Options Vested
AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested
9000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1925000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
24000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-981000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-138949000 USD
CY2020Q3 hims Stock Issued During Period Value Exercises Of Warrants
StockIssuedDuringPeriodValueExercisesOfWarrants
8000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
44000 USD
CY2020Q3 hims Adjustments To Additional Paid In Capital Early Exercised Options Vested
AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested
7000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1414000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-5871000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-143341000 USD
us-gaap Net Income Loss
NetIncomeLoss
-76498000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12885000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2445000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
692000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
55259000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4743000 USD
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
13610000 USD
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
-2477000 USD
hims Noncash Warrant Expense
NoncashWarrantExpense
154000 USD
hims Noncash Warrant Expense
NoncashWarrantExpense
0 USD
hims Lease Termination Expense Noncash
LeaseTerminationExpenseNoncash
0 USD
hims Lease Termination Expense Noncash
LeaseTerminationExpenseNoncash
1846000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
144000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
251000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1732000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-21000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3178000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2635000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-37000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
58000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-871000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6928000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
735000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-777000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6306000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-897000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-794000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1149000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
217000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-65000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-4000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
379000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31307000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2210000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
219361000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
84015000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
99375000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
43790000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
3465000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
11550000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
46468000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments For Software
PaymentsForSoftware
3242000 USD
us-gaap Payments For Software
PaymentsForSoftware
1651000 USD
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
279000 USD
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
1293000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-166510000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31619000 USD
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
0 USD
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
51927000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
22027000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
hims Proceeds From Issuance Of Common Stock Recapitalization
ProceedsFromIssuanceOfCommonStockRecapitalization
197686000 USD
hims Proceeds From Issuance Of Common Stock Recapitalization
ProceedsFromIssuanceOfCommonStockRecapitalization
0 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
75000000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
12851000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2074000 USD
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
1193000 USD
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
787000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
hims Proceeds From Stock Options Exercised Net Of Repurchases
ProceedsFromStockOptionsExercisedNetOfRepurchases
567000 USD
hims Proceeds From Stock Options Exercised Net Of Repurchases
ProceedsFromStockOptionsExercisedNetOfRepurchases
111000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
1515000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5234000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
235121000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
48449000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-26000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-11000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
37278000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14609000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28350000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22797000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65628000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37406000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
279000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
246000 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
10000 USD
hims Stock Expired Redemption Right
StockExpiredRedemptionRight
0 USD
hims Stock Expired Redemption Right
StockExpiredRedemptionRight
4500000 USD
hims Exercise Of Warrants
ExerciseOfWarrants
0 USD
hims Exercise Of Warrants
ExerciseOfWarrants
6508000 USD
us-gaap Recapitalization Costs
RecapitalizationCosts
125000 USD
us-gaap Recapitalization Costs
RecapitalizationCosts
0 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
249837000 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
hims Warrants Assumed
WarrantsAssumed
51814000 USD
hims Warrants Assumed
WarrantsAssumed
0 USD
hims Warrants Redemption Exercised
WarrantsRedemptionExercised
37834000 USD
hims Warrants Redemption Exercised
WarrantsRedemptionExercised
0 USD
hims Reclassification Of Deferred Transaction Costs
ReclassificationOfDeferredTransactionCosts
3929000 USD
hims Reclassification Of Deferred Transaction Costs
ReclassificationOfDeferredTransactionCosts
0 USD
hims Conversion Of Preferred Stock Warrants Amount Converted
ConversionOfPreferredStockWarrantsAmountConverted
1160000 USD
hims Conversion Of Preferred Stock Warrants Amount Converted
ConversionOfPreferredStockWarrantsAmountConverted
0 USD
hims Deferred Transaction Costs Payable
DeferredTransactionCostsPayable
0 USD
hims Deferred Transaction Costs Payable
DeferredTransactionCostsPayable
577000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
35000 USD
hims Transaction Costs Incurred But Not Yet Paid
TransactionCostsIncurredButNotYetPaid
568000 USD
hims Transaction Costs Incurred But Not Yet Paid
TransactionCostsIncurredButNotYetPaid
0 USD
hims Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
147000 USD
hims Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
27000 USD
hims Stock Issued And Contingent Consideration For Business Acquisition
StockIssuedAndContingentConsiderationForBusinessAcquisition
99958000 USD
hims Stock Issued And Contingent Consideration For Business Acquisition
StockIssuedAndContingentConsiderationForBusinessAcquisition
0 USD
hims Equity Awards Classified As Prepaid Expenses
EquityAwardsClassifiedAsPrepaidExpenses
2625000 USD
hims Equity Awards Classified As Prepaid Expenses
EquityAwardsClassifiedAsPrepaidExpenses
0 USD
CY2021Q1 hims Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.4530
us-gaap Use Of Estimates
UseOfEstimates
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The more significant estimates and assumptions by management include, among others, valuation of inventory, valuation and recognition of stock-based compensation expense, valuation and recognition of warrants, valuation of contingent consideration in business combinations, purchase price allocation for business combinations, valuation of earn-out liabilities, and estimates in capitalization of website development and internal-use software costs. Management believes that the estimates and judgments upon which it relies, are reasonable based upon information available to it at the time that these estimates and judgments were made. Actual results experienced by the Company may differ from management’s estimates. To the extent that there are material differences between these estimates and actual results, the Company’s condensed consolidated financial statements will be affected.
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74173000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64772000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27344000 USD
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
856000 USD
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1006000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65628000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28350000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41324000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
187179000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
107291000 USD
CY2021Q1 hims Reverse Recapitalization Percentage Of Voting Interests Acquired
ReverseRecapitalizationPercentageOfVotingInterestsAcquired
1
CY2021Q1 hims Proceeds From Issuance Of Common Stock Recapitalization
ProceedsFromIssuanceOfCommonStockRecapitalization
197700000 USD
CY2021Q1 hims Reverse Recapitalization Transaction Costs
ReverseRecapitalizationTransactionCosts
18700000 USD
CY2021Q1 hims Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.4530
CY2021Q1 hims Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.4530
CY2021Q1 hims Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.4530
CY2021Q1 hims Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.4530
CY2021Q1 hims Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.4530
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Shares
ReverseRecapitalizationContingentConsiderationEquityShares
16000000 shares
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger One
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne
15.00
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Two
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo
17.50
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Three
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree
20.00
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Trading Days
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays
10 D
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Trading Day Period
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod
20 D
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriod
P5Y
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriod
P5Y
us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
2 acquisition
CY2020Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
187664000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
13000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
187653000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
72859000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
72864000 USD
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9230000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2856000 USD
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1628000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
687000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
10858000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
3543000 USD
CY2021Q3 hims Trade And Other Receivables Current
TradeAndOtherReceivablesCurrent
1324000 USD
CY2020Q4 hims Trade And Other Receivables Current
TradeAndOtherReceivablesCurrent
1147000 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8910000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2691000 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
716000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1566000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10950000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5404000 USD
CY2021Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
4344000 USD
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1122000 USD
CY2021Q3 hims Accrued Payroll Costs Current
AccruedPayrollCostsCurrent
3101000 USD
CY2020Q4 hims Accrued Payroll Costs Current
AccruedPayrollCostsCurrent
919000 USD
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
866000 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1241000 USD
CY2021Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
755000 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
651000 USD
CY2021Q3 us-gaap Deposit Liability Current
DepositLiabilityCurrent
0 USD
CY2021Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000 USD
CY2020Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
664000 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2140000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
387000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11206000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4984000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1100000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1700000 USD
CY2020Q1 hims Operating Lease Term Of Contract
OperatingLeaseTermOfContract
P63M
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
7900000 USD
CY2021Q1 hims Lessee Operating Lease Period For Payments Net Of Rent Abatement
LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement
P3M
CY2020Q1 hims Operating Lease Rent Expense Annual Escalation Percent
OperatingLeaseRentExpenseAnnualEscalationPercent
0.025
CY2020Q1 hims Operating Lease Renewal Term
OperatingLeaseRenewalTerm
P5Y
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
384000 USD
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1559000 USD
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1598000 USD
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1638000 USD
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1114000 USD
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
6293000 USD
CY2021Q3 us-gaap Purchase Obligation
PurchaseObligation
2100000 USD
CY2021Q1 hims Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.4530
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.81
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9200000 USD
CY2021Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
11703000 shares
CY2021Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
10346000 shares
CY2021Q1 hims Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.4530
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Two
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo
17.50
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger One
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne
15.00
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Three
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree
20.00
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Trading Days
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays
10 day
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Consecutive Trading Days
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays
20 day
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriod
P5Y
CY2021Q1 hims Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.4530
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger One
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne
15.00
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Two
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo
17.50
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Three
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree
20.00
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Trading Days
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays
10 day
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Consecutive Trading Days
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays
20 day
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriod
P5Y
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11869000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1414000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
55259000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4743000 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
200000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
500000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
95997674 shares
us-gaap Dividends Common Stock
DividendsCommonStock
0 USD
CY2021Q1 hims Number Of Classes Of Common Stock
NumberOfClassesOfCommonStock
2 common_stock_class
CY2021Q1 hims Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.4530
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
95997674 shares
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
93328118 shares
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
93328118 shares
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
268452000 USD
CY2020 hims Proceeds From Issuance Of Temporary Equity
ProceedsFromIssuanceOfTemporaryEquity
238641000 USD
CY2021Q1 hims Recapitalization Exchange Conversion Basis
RecapitalizationExchangeConversionBasis
1
CY2021Q1 hims Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.4530
CY2021Q1 hims Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.4530
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger One
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne
15.00
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Two
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo
17.50
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Three
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree
20.00
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Trading Days
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays
10 day
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Consecutive Trading Days
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays
20 day
CY2021Q1 hims Reverse Recapitalization Contingent Consideration Equity Earnout Period
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriod
P5Y
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.166
CY2020Q3 us-gaap Dividends Common Stock
DividendsCommonStock
0 USD
us-gaap Dividends Common Stock
DividendsCommonStock
0 USD
CY2021Q3 us-gaap Dividends Common Stock
DividendsCommonStock
0 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.005
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.038
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.008
CY2021Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3100000 USD

Files In Submission

Name View Source Status
0001773751-21-000057-index-headers.html Edgar Link pending
0001773751-21-000057-index.html Edgar Link pending
0001773751-21-000057.txt Edgar Link pending
0001773751-21-000057-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hims-20210930.htm Edgar Link pending
hims-20210930.xsd Edgar Link pending
hims-20210930x10qxex311.htm Edgar Link pending
hims-20210930x10qxex312.htm Edgar Link pending
hims-20210930x10qxex321.htm Edgar Link pending
hims-20210930x10qxex322.htm Edgar Link pending
hims-20210930_cal.xml Edgar Link unprocessable
hims-20210930_def.xml Edgar Link unprocessable
hims-20210930_htm.xml Edgar Link completed
hims-20210930_lab.xml Edgar Link unprocessable
hims-20210930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending